Dr. Bradner is a physician and a scientist at the Dana-Farber Cancer Institute and Harvard Medical School. He is a graduate of Harvard College, the University of Chicago-Pritzker School of Medicine and Harvard Medical School. Following completion of clinical training at the Brigham and Farber, and scientific training at Harvard’s Department of Chemistry, he joined the permanent research faculty in 2009. His clinical interests concern the development of new drugs for blood cancers and the care of patients undergoing stem cell transplantation. The focus of the Bradner laboratory concerns the discovery of new cancer drugs targeting gene regulatory networks.
« Go Back